ADPT · Healthcare · $4.6B
$28.61-1.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“이번 분기 가장 빛난 건 혈액암 MRD 검사(clonoSEQ) 사업이에요.”
In the company's words · 2026 1분기 earnings call